FDA Inspection
The American National Red CrossThe American National Red Cross – FDA Inspection, Apr 6, 2012
Record Details
This FDA Inspection record concerns The American National Red Cross, with an inspection on April 6, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- April 6, 2012
- Product Type
- Biologics
View Company Profile
ID · 88636444-267b-418d-8d10-464af7e8f2ba
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 776271
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of The American National Red Cross
11| Date | Classification | Office | Project area |
|---|---|---|---|
| September 11, 2024 | Not classified | Cincinnati District Office | |
| May 13, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 7, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 7, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 2, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for The American National Red Cross
- FDA Inspection 1249340 - 2024-09-11
- FDA Inspection 1170847 - 2022-05-13
- FDA Inspection 1082499 - 2019-03-07
- FDA Inspection 1017349 - 2017-07-07
- FDA Inspection 933441 - 2015-07-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.